GRIN2B and Menkes disease: To further exclude the possibility that NR2B subunits merely participate in the expression but not the restoration of plasticity, we simultaneously administered magnesium and the NR2B antagonist Ro 25-6981 for 2 weeks, followed by the removal of both prior to the onset of MD (Fig. 2c).